🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

367 notícias encontradas para "adult"
New research reveals rise in obesity rates in the US
New research reveals rise in obesity rates in the US
Obesity rates among U.S. adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published in Circulation.
Health apps and feeds reshape doctor visits, surveys of US adults show
Researchers at Yale School of Medicine recently published two new studies in JAMA Network Open and JAMA that offer new insights into how people interact with wearable devices and health-related content on social media.
AI-guided CRISPR uncovers oxytocin receptor as unexpected psoriasis drug target
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis. They found an unlikely candidate: the receptor for oxytocin, a hormone
Kidney disease profile shifts: Diabetes-linked CKD rises as overall US rate stalls
Chronic kidney disease (CKD) is common, largely silent and serious. Most people who have the condition do not realize they have it, while it sharply raises the risk of heart attacks, strokes, kidney failure and early death. Over the past decade, the share of American adults livin
Foto: cottonbro studio / Pexels
Sleep problems in dementia care are linked more to emotional well-being than fear of falli
While fear of falling has long been linked to poor sleep among older adults, new research from George Mason University suggests that emotional well-being may be an even stronger predictor of sleep quality for people with dementia and the spouses who care for them. In what is beli
Foto: Regan Dsouza / Pexels
ADHD medication misuse declines among US adults, study finds
Misuse of stimulant medications for attention-deficit/hyperactivity disorder (ADHD) has declined sharply. In 2023, approximately 3.7% of adults younger than 30 misused these medications, down from 7.5% in 2016. In 2023, 1.9% of adults of all ages misused them, with misuse more co
Simple assessment tools are accurate in predicting older adults' health
Simple assessment tools are accurate in predicting older adults' health
Several tools are currently used to assess the health of older people and their risk of future health problems, but it is unclear which perform best. A new study published in BMC Medicine compares seven widely used geriatric assessment tools. The results show that a relatively si
GLP-1 use hits record high as Medicare opens access to weight-loss drugs
The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. O recorte ajuda a contextualizar a pauta dentro de Fitness.
Lower dementia risk seen with sodium-glucose cotransporter 2 in seniors 65+ with mood, psy
Lower dementia risk seen with sodium-glucose cotransporter 2 in seniors 65+ with mood, psy
Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is associated with a lower risk for dementia in older adults with mood and psychotic disorders, according to a study published online June 30 in JAMA Network Open.
Geriatric patients can independently manage appropriately-designed digital nutrition apps,
In an era where digital health applications are booming, older adults, particularly those facing the physical and psychological toll of post-acute rehabilitation, are frequently left out of the equation because of assumptions about low-tech literacy. However, a prospective pilot
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma p
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma p
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, underscoring the need for i
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes. The